Product Information
QUETIAPINE ER 400 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.3174 per EA under NDC 29300031216. Its NADAC has been published 192 times since Nov 2, 2022.
FDA first approved this application on Aug 15, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300031216
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA215478FDA Approved
8/15/2022
TE Code
AB
On Market Since
8/15/2022
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 400 MG TABLET has been published 192 times since Nov 2, 2022, and over the history we have for it it has declined 37.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3174 per EA |
|---|---|
| All-time high | $0.5069 (Nov 16, 2022) |
| All-time low | $0.2506 (Jul 17, 2024) |
| 52-week high | $0.3390 |
| 52-week low | $0.3021 |
| Median price | $0.3194 |
| Average price | $0.3390 |
| Largest weekly change | +47.1% (Aug 21, 2024) |
| Weeks tracked | 192 |
| Tracking since | Nov 2, 2022 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Unichem Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Quetiapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 400 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.3174 per EA (NDC 29300031216), effective Sep 30, 2026.
How has the price of QUETIAPINE ER 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 400 MG TABLET has declined 37.4%. It has been tracked across 192 weekly CMS publications since Nov 2, 2022.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 400 MG TABLET?
Since Nov 2, 2022, the NADAC for QUETIAPINE ER 400 MG TABLET has ranged from a low of $0.2506 (Jul 17, 2024) to a high of $0.5069 (Nov 16, 2022), with a median of $0.3194 per EA.
Are there cheaper alternatives to QUETIAPINE ER 400 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 400 MG TAB, is $0.1616 per EA — about 49% below QUETIAPINE ER 400 MG TABLET.
Who manufactures QUETIAPINE ER 400 MG TABLET?
QUETIAPINE ER 400 MG TABLET (NDC 29300031216) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.